Profile data is unavailable for this security.
About the company
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
- Revenue in EUR (TTM)351.98k
- Net income in EUR-10.57m
- Incorporated2005
- Employees69.00
- LocationMagforce AGMax-Planck-Strasse 3BERLIN 12489GermanyDEU
- Phone+49 303083800
- Fax+49 3 030838099
- Websitehttps://www.magforce.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paion AG | -100.00bn | -100.00bn | 78.34k | 64.00 | -- | -- | -- | -- | -- | -- | -- | -0.4074 | -- | -- | -- | -- | -- | -24.86 | -- | -34.32 | -- | -- | -- | -52.40 | 0.5078 | -- | 1.17 | -- | 366.42 | 41.74 | 97.34 | -- | 129.37 | -- |
| Scandion Oncology A/S | 0.00 | -4.90m | 113.84k | 4.00 | -- | 0.103 | -- | -- | -0.2743 | -0.2743 | 0.00 | 0.0524 | 0.00 | -- | -- | 0.00 | -138.75 | -- | -186.13 | -- | -- | -- | -- | -- | -- | -- | 0.0079 | -- | -- | -- | 6.49 | -- | -- | -- |
| MagForce AG | 351.98k | -10.57m | 164.62k | 69.00 | -- | 0.0061 | -- | 0.4677 | -0.3531 | -0.3531 | 0.0118 | 0.8967 | 0.0055 | 3.47 | 0.8532 | 5,101.16 | -16.47 | -3.78 | -31.53 | -6.78 | -89.95 | 25.30 | -3,004.22 | -295.23 | 0.0321 | -1.97 | 0.2485 | -- | -43.33 | -5.77 | -171.71 | -- | -- | -- |
| Oxurion NV | 3.00k | 119.00k | 263.39k | 11.00 | -- | -- | 1.01 | 87.80 | -1.48 | -1.48 | 0.0014 | -3.46 | 0.0005 | -- | 0.0018 | 272.73 | 1.94 | -101.52 | -- | -249.96 | -1,333.33 | 53.85 | 3,966.67 | -2,672.68 | -- | 1.47 | 42.11 | -- | -98.86 | -76.22 | 100.63 | -- | -- | -- |
| Epigenomics AG | 0.00 | -3.35m | 542.79k | 2.00 | -- | -- | -- | -- | -3.82 | -3.82 | 0.00 | 0.00 | -- | -- | -- | 0.00 | -- | -55.09 | -- | -61.61 | -- | -0.2095 | -- | -473.65 | -- | -- | 1.00 | -- | -100.00 | -- | 24.90 | -- | -- | -- |
| Neovacs SA | 291.30k | -32.91m | 582.62k | 20.00 | -- | 0.00003 | -- | 2.00 | -33,191.96 | -33,191.96 | 3.32 | 103.50 | 0.0078 | -- | 0.663 | 14,565.00 | -88.20 | -34.19 | -98.13 | -38.39 | -11.20 | -128.93 | -11,299.15 | -7,195.39 | -- | -- | 0.0126 | -- | -45.39 | -- | -276.45 | -- | 102.34 | -- |
| bioXXmed AG | 4.99k | -21.00m | 652.48k | 1.00 | -- | 2.79 | -- | 130.76 | -34.12 | -34.12 | 0.0107 | 0.1722 | 0.0005 | -- | 0.0993 | 4,990.00 | -194.29 | -32.69 | -195.04 | -33.41 | -- | -- | -420,847.50 | -19,770.58 | -- | -0.0444 | 0.00 | -- | 42.27 | -- | -2,424.48 | -- | -- | -- |
| Lidds AB | 0.00 | -650.80k | 792.64k | 1.00 | -- | 2.72 | -- | -- | -0.059 | -0.059 | 0.00 | 0.0238 | 0.00 | -- | -- | 0.00 | -75.64 | -64.76 | -96.24 | -76.72 | -- | -1,554.86 | -- | -2,637.08 | -- | -- | 0.1807 | -- | -- | -- | 85.23 | -- | -65.39 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Ruffer LLPas of 28 Feb 2025 | 112.03k | 0.37% |
